Nanoparticle-Based Nitric Oxide Donors: Exploring Their Antimicrobial and Anti-Biofilm Capabilities
Gonzalo Tortella Fuentes,
Paola Fincheira,
Olga Rubilar,
Sebastian Leiva,
Ivette Fernandez,
Mauricio Schoebitz,
Milena T. Pelegrino,
André Paganotti,
Roberta Albino dos Reis,
Amedea B. Seabra
Affiliations
Gonzalo Tortella Fuentes
Centro de Excelencia en Investigación Biotecnológica Aplicada al Medio Ambiente-CIBAMA, Facultad de Ingeniería y Ciencias, Universidad de La Frontera, Temuco 4811230, Chile
Paola Fincheira
Centro de Excelencia en Investigación Biotecnológica Aplicada al Medio Ambiente-CIBAMA, Facultad de Ingeniería y Ciencias, Universidad de La Frontera, Temuco 4811230, Chile
Olga Rubilar
Centro de Excelencia en Investigación Biotecnológica Aplicada al Medio Ambiente-CIBAMA, Facultad de Ingeniería y Ciencias, Universidad de La Frontera, Temuco 4811230, Chile
Sebastian Leiva
Centro de Excelencia en Investigación Biotecnológica Aplicada al Medio Ambiente-CIBAMA, Facultad de Ingeniería y Ciencias, Universidad de La Frontera, Temuco 4811230, Chile
Ivette Fernandez
Centro de Excelencia en Investigación Biotecnológica Aplicada al Medio Ambiente-CIBAMA, Facultad de Ingeniería y Ciencias, Universidad de La Frontera, Temuco 4811230, Chile
Mauricio Schoebitz
Departamento de Suelos y Recursos Naturales, Facultad de Agronomía, Campus Concepción, Universidad de Concepción, Casilla 160-C, Concepción 4030000, Chile
Milena T. Pelegrino
MirScience Therapeutics, São Paulo 04020-040, SP, Brazil
André Paganotti
Departamento de Farmácia, Universidade Federal de São Paulo, Diadema 09972-270, SP, Brazil
Roberta Albino dos Reis
Centro de Ciências Naturais e Humanas, Universidade Federal do ABC, Santo André 09606-045, SP, Brazil
Amedea B. Seabra
Centro de Ciências Naturais e Humanas, Universidade Federal do ABC, Santo André 09606-045, SP, Brazil
Background: Nitric oxide (NO) is an antimicrobial and anti-biofilm agent with significant potential for combating biofilm-associated infections and antibiotic resistance. However, owing to its high reactivity due to the possession of a free radical and short half-life (1–5 s), the practical application of NO in clinical settings is challenging. Objectives: This review explores the development of NO-releasing nanoparticles that provide a controlled, targeted delivery system for NO, enhancing its antimicrobial efficacy while minimizing toxicity. The review discusses various NO donors, nanoparticle platforms, and how NO disrupts biofilm formation and eradicates pathogens. Additionally, we examine the highly encouraging and inspiring results of NO-releasing nanoparticles against multidrug-resistant strains and their applications in medical and environmental contexts. This review highlights the promising role of NO-based nanotechnologies in overcoming the challenges posed by increasing antibiotic resistance and biofilm-associated infections. Conclusions: Although NO donors and nanoparticle delivery systems show great potential for antimicrobial and anti-biofilm uses, addressing challenges related to controlled release, toxicity, biofilm penetration, resistance, and clinical application is crucial.